BACKGROUND
Since 1981 Princess Margaret Hospital has used initial active surveillance (AS) with delayed treatment at relapse as the preferred management for all patients with clinical stage I… (More)
OBJECTIVES
To review treatment outcome and patterns of failure for patients with stage II testicular seminoma and to identify prognostic factors for relapse.
METHODS
From 1981 to 1999, 126 men with… (More)
BACKGROUND
After orchidectomy, the standard management options available for stage I seminoma are surveillance, adjuvant radiotherapy, or adjuvant chemotherapy. The optimal follow-up protocol for… (More)
Journal of clinical oncology : official journal…
2012
328 Background: Use of GCSF and the development of renal impairment in GCT pts receiving chemo are common, but their effect on toxicity and survival is unclear. This study examines the impact of GCSF… (More)
Malignant teratoma of the thyroid gland is exceedingly rare in adults. Many of the cases previously reported in the medical literature have fatal outcomes because of spread of tumor refractory to… (More)
Journal of clinical oncology : official journal…
2002
PURPOSE
The benefits of recording the tumor, node, and metastasis (TNM) stages of cancer patients are well accepted, but little is known about how accurately this is performed. An audit was performed… (More)
Journal of clinical oncology : official journal…
2015
PURPOSE
Cisplatin-based chemotherapy, a mainstay of treatment for disseminated germ cell tumors (GCTs), is associated with venous thromboembolism (VTE). Many patients with disseminated GCTs have… (More)
Journal of clinical oncology : official journal…
2012
332 Background: VTE causes significant morbidity and mortality in GCT pts. While an existing and validated predictive model identifies VTE risk in chemo pts with any cancer (Khorana model), a… (More)
PURPOSE
Prophylactic left supraclavicular fossa irradiation has been suggested to reduce relapse rates in patients treated for Stage IIA/B testicular seminoma. To address this issue, we reviewed… (More)